Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland

Bone Marrow Transplantation

Volumn 37, Issue 10, 2006, Pages 909-916

  Chalandon, Y ^a   Tiercy, J M ^b   Schanz, U ^c   Gungor, T ^d   Seger, R ^d   Halter, J ^c   Helg, C ^a   Chapuis, B ^a   Gratwohl, A ^e   Tichelli, A ^e   Nicoloso de Faveri, G ^f   Roosnek, E ^a   Passweg, J R ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b National Reference Laboratory for Histocompatibility   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f Swiss Bone Marrow Donor Registry   (Switzerland)

Author keywords

GVHD; Molecular HLA matching; Relapse; TRM

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC MYELOID LEUKEMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DONOR SELECTION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROBABILITY; RECIPIENT; REDUCED INTENSITY CONDITIONING; SURVIVAL RATE; SWITZERLAND; T CELL DEPLETION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INFANT; LIVING DONORS; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; SWITZERLAND;

EID: 33646927770     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705353     Document Type: Article

References (39)

1. Petersdorf EW, Malkki M. Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation. Semin Hematol 2005; 42: 76-84.
2. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplant 2006; 37: 439-449.
3. Hansen JA, Petersdorf E, Martin PJ, Anasetti C. Hematopoietic stem cell transplants from unrelated donors. Immunol Rev 1997; 157: 141-151.
4. Madrigal JA, Scott I, Arguello R, Szydlo R, Little AM, Goldman JM. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997; 157: 153-166.
5. Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998; 339: 1177-1185.
6. Scott I, O'Shea J, Bunce M, Tiercy JM, Arguello JR, Firman H et al. Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: Implications for unrelated bone marrow donor selection. Blood 1998; 92: 4864-4871.
7. Prasad VK, Kernan NA, Heller G, O'Reilly RJ, Yang SY. DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1. Blood 1999; 93: 399-409.
8. Tiercy JM, Morel C, Freidel AC, Zwahlen F, Gebuhrer L, Betuel H et al. Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc Natl Acad Sci USA 1991; 88: 7121-7125.
9. Speiser DE, Tiercy JM, Rufer N, Grundschober C, Gratwohl A, Chapuis B et al. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996; 87: 4455-4462.
10. Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92: 3515-3520.
11. Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004; 104: 1923-1930.
12. Beatty PG, Anasetti C, Hansen JA, Longton GM, Sanders JE, Martin PJ et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mismatching for one HLA locus. Blood 1993; 81: 249-253.
13. Davies SM, Shu XO, Blazar BR, Filipovich AH, Kersey JH, Krivit W et al. Unrelated donor bone marrow transplantation: Influence of HLA A and B incompatibility on outcome. Blood 1995; 86: 1636-1642.
14. Petersdorf EW, Longton GM, Anasetti C, Martin PJ, Mickelson EM, Smith AG et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606-1613.
15. Nagler A, Brautbar C, Slavin S, Bishara A. Bone marrow transplantation using unrelated and family related donors: The impact of HLA-C disparity. Bone Marrow Transplant 1996; 18: 891-897.
16. Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, Smith AG, Martin PJ et al. Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci USA 1996; 93: 15358-15363.
17. Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997; 89: 1818-1823.
18. Gajewski J, Gjertson D, Cecka M, Tonai R, Przepiorka D, Hunt L et al. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation. Biol Blood Marrow Transplant 1997; 3: 76-82.
19. Petersdorf EW, Kollman C, Hurley CK, Dupont B, Nademanee A, Begovich AB et al. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: The US National Marrow Donor Program Experience. Blood 2001; 98: 2922-2929.
20. Petersdorf EW, Gooley T, Malkki M, Anasetti C, Martin P, Woolfrey A et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 2001; 112: 988-994.
21. Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002; 99: 4200-4206.
22. Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997; 89: 4226-4235.
23. McGlave PB, Shu XO, Wen W, Anasetti C, Nademanee A, Champlin R et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program. Blood 2000; 95: 2219-2225.
24. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: The effect of donor age. Blood 2001; 98: 2043-2051.
25. Roosnek E, Tiercy JM. Search for an unrelated HLA-compatible stem cell donor. Curr Opin Hematol 1999; 6: 365-370.
26. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100.
27. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005; 5: 201-214.
28. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
29. Kaplan EL, Meier O. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
30. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 695-706.
31. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
32. Tiercy JM, Passweg J, Van Biezen A, Zander A, Kroger N, Gratwohl A et al. Isolated HLA-C mismatches in unrelated donor transplantation for CML. Bone Marrow Transplant 2004; 34: 249-255.
33. Petersdorf EW, Anasetti C, Martin PJ, Gooley T, Radich J, Malkki M et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 2004; 104: 2976-2980.
34. Mori M, Beatty PG, Graves M, Boucher KM, Milford EL. HLA gene and haplotype frequencies in the North American population: The National Marrow Donor Program Donor Registry. Transplantation 1997; 64: 1017-1027.
35. Oh H, Loberiza Jr FR, Zhang MJ, Ringden O, Akiyama H, Asai T et al. Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood 2005; 105: 1408-1416.
36. Greinix HT, Fae I, Schneider B, Rosenmayr A, Mitterschiffthaler A, Pelzmann B et al. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant 2005; 35: 57-62.
37. Ottinger HD, Ferencik S, Beelen DW, Lindemann M, Peceny R, Elmaagacli AH et al. Impact of HLA-A, B, C allele mismatches on outcome after unrelated blood stem cell transplantation in whites. Transplantation 2004; 78: 1077-1080.
38. Moretta L, Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol 2004; 16: 626-633.
39. Malmberg KJ, Schaffer M, Ringden O, Remberger M, Ljunggren HG. KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation. Mol Immunol 2005; 42: 531-534.